Literature DB >> 18536606

Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections.

John J de Caro1, Christopher N Ta, Hoai-Ky V Ho, Lorella Cabael, Nan Hu, Steven R Sanislo, Mark S Blumenkranz, Darius M Moshfeghi, Robert Jack, Herminia Miño de Kaspar.   

Abstract

PURPOSE: To evaluate potential sources of bacterial contamination during intravitreal (IVT) injection procedures.
METHODS: Patients scheduled for IVT injection were asked to enroll in the study at the California Vitreoretinal Center (Menlo Park, CA) and the Vantage Eye Center (Salinas, CA) between October 2004 and April 2005. A total of 104 patients participated in the study, with a total of 118 IVT injection procedures performed on 107 eyes. Standard microbiological techniques were used to culture, identify, and quantify bacterial contamination of injection needles and the bulbar conjunctiva at the injection site in patients undergoing IVT injections. The main outcomes measured were type and quantity of bacterial isolates.
RESULTS: Two (2%) of 114 needles collected were contaminated with bacteria. The prevalence of bacterial contamination of the injection site on the bulbar conjunctiva was 43% before prophylaxis on the day of the injection with topical antibiotics and povidone-iodine, with a statistically significant reduction to 13% after prophylaxis (P < 0.0001). Coagulase-negative Staphylococcus, the most common bacterium isolated from the ocular surface, was isolated from both culture-positive needles.
CONCLUSIONS: IVT injection needles became contaminated with bacteria during the injection procedure. Although the contamination rate was low, this supports a mechanism of postinjection endophthalmitis in which there is direct inoculation of ocular surface flora into the vitreous cavity by the injection needle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536606     DOI: 10.1097/IAE.0b013e31816b3180

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

1.  Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review.

Authors:  Francesca Menchini; Giacomo Toneatto; Alba Miele; Simone Donati; Paolo Lanzetta; Gianni Virgili
Journal:  Eye (Lond)       Date:  2018-06-11       Impact factor: 3.775

2.  [Bacterial contamination of needles after intravitreal injection in Paraguay].

Authors:  J C Gines; M M Nentwich; A H Peggy Bedoya; P Cibils; A Esteche; F Laspina; M Samudio; N Fariña; H M de Kaspar
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

3.  Combination of lidocaine gel and povidone-iodine to decrease acquired infections in procedures performed using topical anesthesia.

Authors:  Julia Xia; Riley J Lyons; Mung Yan Lin; Yousuf M Khalifa; Christopher N LaRock
Journal:  J Cataract Refract Surg       Date:  2020-07       Impact factor: 3.351

4.  Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes.

Authors:  Ajay E Kuriyan; Kathleen D Weiss; Harry W Flynn; William E Smiddy; Audina M Berrocal; Thomas A Albini; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2014-01-10       Impact factor: 5.258

5.  Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).

Authors:  Travis A Meredith; Colin A McCannel; Charles Barr; Bernard H Doft; Ellen Peskin; Maureen G Maguire; Daniel F Martin; Jonathan L Prenner
Journal:  Ophthalmology       Date:  2015-01-15       Impact factor: 12.079

6.  Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection.

Authors:  Yasushi Ikuno; Miki Sawa; Motokazu Tsujikawa; Fumi Gomi; Naoyuki Maeda; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-06-28       Impact factor: 2.447

Review 7.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.

Authors:  Deepa Talreja; Keith S Kaye; Fu-shin Yu; Satish K Walia; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-15       Impact factor: 4.799

9.  Novel Needle for Intravitreal Drug Delivery: Comparative Study of Needle Tip Aspirates, Injection Stream and Penetration Forces.

Authors:  Lyubomyr M Lytvynchuk; Goran Petrovski; Adien Dam; Joep Hiemstra; Tobias Wimmer; Iryna Savytska; Susanne Binder; Knut Stieger
Journal:  Clin Ophthalmol       Date:  2021-02-19

Review 10.  Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis.

Authors:  Cédric Benoist d'Azy; Bruno Pereira; Geraldine Naughton; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.